Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib

A. Zhou; E. M. Knoche; E. K. Engle; D. A.C. Fisher; S. T. Oh

doi:10.1038/bcj.2015.77

Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib

A. Zhou, E. M. Knoche, E. K. Engle, D. A.C. Fisher, S. T. Oh

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	e351
Journal	Blood cancer journal
Volume	5
DOIs	https://doi.org/10.1038/bcj.2015.77
State	Published - Oct 2 2015

Access to Document

10.1038/bcj.2015.77

Cite this

@article{1c13c37b7ec94dc98c8f03e5e1c313db,

title = "Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib",

author = "A. Zhou and Knoche, {E. M.} and Engle, {E. K.} and Fisher, {D. A.C.} and Oh, {S. T.}",

note = "Funding Information: This work was supported by NIH grants K08HL106576 (Oh), K12HL087107 (Oh) and T32HL007088 (Engle, Fisher). Technical support was provided by the Alvin J. Siteman Cancer Center Tissue Procurement and Flow Cytometry Cores, which are supported by NCI Cancer Center Support Grant P30CA91842. We thank D. Moore for assistance with tissue banking, and L. He, G. Rippberger and M. Fulbright for assistance with JAK2 and BCR-ABL genotyping experiments.",

year = "2015",

month = oct,

day = "2",

doi = "10.1038/bcj.2015.77",

language = "English",

volume = "5",

pages = "e351",

journal = "Blood cancer journal",

issn = "2044-5385",

}

TY - JOUR

T1 - Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib

AU - Zhou, A.

AU - Knoche, E. M.

AU - Engle, E. K.

AU - Fisher, D. A.C.

AU - Oh, S. T.

N1 - Funding Information: This work was supported by NIH grants K08HL106576 (Oh), K12HL087107 (Oh) and T32HL007088 (Engle, Fisher). Technical support was provided by the Alvin J. Siteman Cancer Center Tissue Procurement and Flow Cytometry Cores, which are supported by NCI Cancer Center Support Grant P30CA91842. We thank D. Moore for assistance with tissue banking, and L. He, G. Rippberger and M. Fulbright for assistance with JAK2 and BCR-ABL genotyping experiments.

PY - 2015/10/2

Y1 - 2015/10/2

UR - http://www.scopus.com/inward/record.url?scp=84943187510&partnerID=8YFLogxK

U2 - 10.1038/bcj.2015.77

DO - 10.1038/bcj.2015.77

M3 - Article

C2 - 26430722

AN - SCOPUS:84943187510

SN - 2044-5385

VL - 5

SP - e351

JO - Blood cancer journal

JF - Blood cancer journal

ER -

Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib

Access to Document

Other files and links

Cite this